Publications by authors named "Lisa Naeger"

Claim this Profile
H
Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays.
Patrick R Harrington, Takashi E Komatsu, Hengrui Sun, Lisa K Naeger

Clin Infect Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hepatitis C virus polymorphisms on direct-acting antiviral treatment efficacy: Regulatory analyses and perspectives.
Patrick R Harrington, Takashi E Komatsu, Damon J Deming, Eric F Donaldson, Julian J O'Rear, Lisa K Naeger

Hepatology· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit-risk assessment for sofosbuvir/velpatasvir/voxilaprevir based on patient population and hepatitis C virus genotype: U. S. Food and Drug Administration's evaluation.
Kimberly Struble, Kirk Chan-Tack, Karen Qi, Lisa K Naeger, Debra Birnkrant

Hepatology· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of dolutegravir functional monotherapy on HIV-1 virological response in integrase strand transfer inhibitor resistant patients.
Lisa K Naeger, Patrick Harrington, Takashi Komatsu, Damon Deming

Antivir Ther· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Analysis of Effects of Hepatitis C Virus NS5A Polymorphisms on Efficacy of Elbasvir and Grazoprevir.
Takashi E Komatsu, Sarita Boyd, Adam Sherwat, LaRee Tracy, Lisa K Naeger

Gastroenterology· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory evaluation of antiviral drug resistance in the era of next-generation sequencing.
Eric F Donaldson, Damon J Deming, Julian J O'Rear, Lisa K Naeger

Biomark Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatitis C Virus RNA Levels During Interferon-Free Combination Direct-Acting Antiviral Treatment in Registrational Trials.
Patrick R Harrington, Damon J Deming, Takashi E Komatsu, Lisa K Naeger

Clin Infect Dis· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir.
Eric F Donaldson, Patrick R Harrington, Julian J O'Rear, Lisa K Naeger

Hepatology· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA perspective on sofosbuvir therapy for patients with chronic hepatitis C virus genotype 1 infection who did not respond to treatment with pegylated interferon and ribavirin.
Poonam Mishra, Jeffry Florian, Karen Qi, Wen Zeng, Lisa K Naeger

Gastroenterology· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance of human cytomegalovirus to ganciclovir/valganciclovir: a comprehensive review of putative resistance pathways.
Takashi E Komatsu, Andreas Pikis, Lisa K Naeger, Patrick R Harrington

Antiviral Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects.
Jiang Liu, Pravin R Jadhav, Shashi Amur, Russell Fleischer, Thomas Hammerstrom, Lisa Naeger

Hepatology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: To PMID 22095516.
Patrick R Harrington, Lisa K Naeger, Wen Zeng

Hepatology· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment.
Patrick R Harrington, Wen Zeng, Lisa K Naeger

Hepatology· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Information Management System (AIMS): a prototype for operational innovation in drug development.
Pravin R Jadhav, Lauren Neal, Jeff Florian, Ying Chen, Lisa Naeger

J Clin Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Running a tightrope: regulatory challenges in the development of antiretrovirals.
Lisa K Naeger, Kimberly A Struble, Jeffrey S Murray, Debra B Birnkrant

Antiviral Res· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food and Drug Administration analysis of tipranavir clinical resistance in HIV-1-infected treatment-experienced patients.
Lisa K Naeger, Kimberly A Struble

AIDS· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of baseline protease genotype and phenotype on HIV response to atazanavir/ritonavir in treatment-experienced patients.
Lisa K Naeger, Kimberly A Struble

AIDS· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir.
Steve Tuske, Stefan G Sarafianos, Arthur D Clark, Jianping Ding, Lisa K Naeger

Nat Struct Mol Biol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
Kirsten L White, James M Chen, Nicolas A Margot, Terri Wrin, Christos J Petropoulos, Lisa K Naeger

Antimicrob Agents Chemother· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT4 requires the N-terminal domain for efficient phosphorylation.
Hua-Chen Chang, Shangming Zhang, India Oldham, Lisa Naeger, Timothy Hoey

J Biol Chem· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses.
Timothy Hoey, Shangming Zhang, Nathan Schmidt, Qing Yu, Shyam Ramchandani, Lisa K Naeger

EMBO J· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.
Kirsten L White, Nicolas A Margot, Terri Wrin, Christos J Petropoulos, Michael D Miller, Lisa K Naeger

Antimicrob Agents Chemother· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.
Lisa K Naeger, Nicolas A Margot, Michael D Miller

Antimicrob Agents Chemother· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Th1 cells regulate hematopoietic progenitor cell homeostasis by production of oncostatin M.
Hal E Broxmeyer, Heather A Bruns, Shangming Zhang, Scott Cooper, Giao Hangoc, Lisa K Naeger

Immunity· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis